|
Çѱ¹MSD ÁÖ½Äȸ»ç |
ID/Vaccine MSL ¸ðÁý
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Çмú/±³À°/»ó´ã |
2³â¡è |
ä¿ë½Ã |
03.11 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Çѱ¹Organon- ´ëÀü Á¦¾à¿µ¾÷ 2¸í ¸ðÁý(½ÅÀÔ°¡´É/°è¾àÁ÷)
´ëÀü ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.04 |
|
|
(ÁÖ)´ÙÀ̾Ƶ§Æ® |
(ÁÖ)´ÙÀ̾Ƶ§Æ® ÁøÃëÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀλçÃѹ« Á÷¿ø ¸ðÁý
ÃæºÏ û¿ø±º | ´ëÇÐ(2~3³â) Á¹¾÷ |
Àλç/ÀÎÀç°³¹ß/ä¿ë/±³À° |
2³â¡è |
ä¿ë½Ã |
03.04 |
|
|
ÁÖ½Äȸ»ç ÀνºÆÃÅͽº |
[Sexual Healthcare EVE] Á¦Ç°°³¹ß Á¤±ÔÁ÷ ä¿ë(½ÅÀÔ/°æ·Â)
¼¿ï ÀüÁö¿ª, °æ±â Çϳ²½Ã | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
03.02 |
|
|
ÁÖ½Äȸ»ç ÀνºÆÃÅͽº |
[Sexual Healthcare EVE] ÀÎÇã°¡(RA) Á¤±ÔÁ÷ ä¿ë(½ÅÀÔ/°æ·Â
¼¿ï ÀüÁö¿ª, °æ±â Çϳ²½Ã | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.02 |
|
|
(ÁÖ)Æĸã½Å |
ÀÓ»ó CRA / CRM °æ·ÂÀÚ Ã¤¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
4³â¡è |
»ó½Ãä¿ë |
02.08 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
02.08 |
|
|
(ÁÖ)ÀÌÁö¼Ö·çÅØ |
GMPÀÎÁõ ÄÁ¼³ÅÏÆ® ¸ðÁý(ÀÇ·á±â±â)
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
¼ö½Ãä¿ë |
2³â¡è |
ä¿ë½Ã |
02.04 |
|
|
Çѱ¹Organon |
Çѱ¹Organon Market Access ´ã´çÀÚ ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
01.15 |
|
|
(ÁÖ)¸ÞµåÆÄÅ© |
(ÁÖ)¸ÞµåÆÄÅ© [¼¿ï / Àü±¹] ±¹Ã¥°úÁ¦ ´ã´ç ä¿ë (±¹Ã¥°úÁ¦
¼¿ï ¿µµîÆ÷±¸, ºÎ»ê ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
ÇϹݱ⠻ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.23 |
|
|
ÀºÁØÆʹÙÀÌ¿À |
°æ·ÂÁ÷ ¿µ¾÷»ç¿ø
°æ±â ÀüÁö¿ª | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
»ó½Ãä¿ë |
12.11 |
|
|
Çѱ¹Organon |
Çѱ¹Organon-Market Access Specialist 1¸í ¸ðÁý
¼¿ï Á¾·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
12.04 |
|
|
¿ÍÀ̺극ÀÎ |
[ÀÇ·á±â±â] Çã°¡ÀÓ»ó °ü¸® ´ã´çÀÚ Ã¤¿ë(CRM/Clinical operat
°æ±â ¼º³²½Ã ¼öÁ¤±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
11.18 |
|
|
(ÁÖ)Á¦³ë½º |
(ÁÖ)Á¦³ë½º »ý»êÆÀ(Àü°î°øÀå) Á¤±ÔÁ÷ ¸ðÁý (ȼº Àü°î»ê¾÷´Ü
°æ±â ȼº½Ã | °íµîÇб³ |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
°æ·Â¹«°ü |
ä¿ë½Ã |
11.18 |
|
|
¾ÆÀ̵¦½º·¡¹ö·¯Å丮½º |
[IDEXX](¿µ¾÷/¿ï»ê,ºÎ»ê) Veterinary Diagnostic Consultant
¿ï»ê ÀüÁö¿ª, ºÎ»ê ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
11.03 |
|